PAGAN, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 2.891
EU - Europa 1.705
AS - Asia 768
SA - Sud America 6
AF - Africa 5
OC - Oceania 5
Totale 5.380
Nazione #
US - Stati Uniti d'America 2.866
DE - Germania 537
IT - Italia 413
SG - Singapore 282
SE - Svezia 233
CN - Cina 172
IE - Irlanda 169
RU - Federazione Russa 157
HK - Hong Kong 114
VN - Vietnam 92
GB - Regno Unito 54
FR - Francia 39
IN - India 34
ID - Indonesia 27
UA - Ucraina 24
CA - Canada 23
DK - Danimarca 21
FI - Finlandia 12
KR - Corea 8
NL - Olanda 7
ES - Italia 6
JP - Giappone 6
TR - Turchia 6
AU - Australia 5
BE - Belgio 5
BR - Brasile 5
RO - Romania 5
MY - Malesia 4
PK - Pakistan 4
PL - Polonia 4
AT - Austria 3
BG - Bulgaria 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
IL - Israele 3
IR - Iran 3
TH - Thailandia 3
TW - Taiwan 3
HU - Ungheria 2
LB - Libano 2
LT - Lituania 2
PR - Porto Rico 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
BD - Bangladesh 1
BJ - Benin 1
ET - Etiopia 1
GR - Grecia 1
JO - Giordania 1
NG - Nigeria 1
PT - Portogallo 1
SI - Slovenia 1
UZ - Uzbekistan 1
Totale 5.380
Città #
Ann Arbor 818
Frankfurt am Main 508
Fairfield 259
Singapore 242
Wilmington 210
Dublin 160
Houston 131
Ashburn 126
Milan 121
Chandler 116
Hong Kong 113
Santa Clara 110
Seattle 100
Woodbridge 94
New York 92
Princeton 88
Cambridge 78
Dearborn 54
Dong Ket 49
Altamura 45
Lawrence 43
San Diego 39
Shanghai 36
Nanjing 32
Jakarta 27
Beijing 24
Guangzhou 21
Chicago 17
Sacramento 17
Ardea 16
Jacksonville 16
Andover 13
Umeå 12
Carate Brianza 11
Naples 11
Toronto 11
London 10
Monza 10
Mumbai 10
Helsinki 9
Redmond 9
Paris 8
Hangzhou 7
Nanchang 7
Pavia 7
Pune 7
Dallas 6
Los Angeles 6
Molteno 6
Ottawa 6
Boardman 5
Brussels 5
Busto Arsizio 5
College Station 5
Edmonton 5
Ningbo 5
Norwalk 5
Sorso 5
Bau 4
Bonndorf 4
Cagliari 4
Florence 4
Gainesville 4
Kunming 4
Marietta 4
Munich 4
Rome 4
Warsaw 4
Ansan-si 3
Atlanta 3
Bangkok 3
Bergamo 3
Bologna 3
Brescia 3
Changsha 3
Coimbatore 3
Cologno Monzese 3
Fremont 3
Heilbronn 3
Huskvarna 3
Kardzhali 3
Kiev 3
Laurel 3
San Mateo 3
Shenyang 3
Stockholm 3
São Luís 3
Villa Literno 3
Arco 2
Arcore 2
Arezzo 2
Beirut 2
Bengaluru 2
Brno 2
Buccinasco 2
Budapest 2
Casorate Sempione 2
Ciserano 2
Colchester 2
Columbus 2
Totale 4.132
Nome #
Joinpoint regression analysis with time-on-study as time-scale. Application to three Italian population-based cohort studies 397
Laryngeal cancer mortality trends in European countries 256
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 212
Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ 209
Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study 205
Sex-based differences of the Tumor mutational burden and T-cell inflammation of the tumor microenvironment 203
Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers 192
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast 189
Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial 187
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis 178
Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines 173
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 152
Endocrine-responsive lobular carcinoma of the breast: Features associated with risk of late distant recurrence 151
Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial 144
Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy 123
Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.” 123
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 118
Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up 117
The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients 115
Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis 111
Evaluation of endocrine therapy and patients preferences in early breast cancer: results of Elena study 106
Sex-based differences in cancer immunotherapy efficacy 96
Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland 96
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 92
How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance? 92
Different Response to Immunotherapy According to Melanoma Histologic Subtype 92
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk) 88
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion 87
Intra- inter-observer repeatability in liver computed tomography volumetry in patients undergoing radioembolization simulation 86
Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer? 85
Prognostic impact of baseline immunologic profile in aggressive b-cell non-hodgkin's lymphomas 80
How to Perform Repeat Sentinel Node Biopsy Safely After a Previous Mastectomy: Technical Features and Oncologic Outcomes 74
Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis 74
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment - Authors' reply 72
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations 68
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy 65
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 61
Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis 60
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy 58
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials 58
Comparison of Trends in Mortality from Coronary Heart and Cerebrovascular Diseases in North and South America: 1980 to 2013 52
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients 45
"Heterogeneity of treatment effect on patients' long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer." 41
Association of prebiotic fiber intake with colorectal cancer risk: the PrebiotiCa study 40
Ten-year outcome results of cT4 breast cancer after neoadjuvant treatment 37
Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis 37
Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis 37
Systematic review and meta-analysis of post-progression outcomes in ER+/HER2− metastatic breast cancer after CDK4/6 inhibitors within randomized clinical trials 34
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis 33
Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study 33
Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center 33
Pegylated liposomal doxorubicin (Caelyx®) as adjuvant treatment in early-stage luminal b-like breast cancer: A feasibility phase II trial 33
Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials 31
Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study 24
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis 22
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer 22
Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis 18
Male breast cancer: a multicenter study to provide a guide for proper management 18
Results of the Italian cross-sectional web-based survey “Nutrition and breast cancer, what would you like to know?” An attempt to collect and respond to patients’ information needs, through social media 11
Development and Validation of a Natural Language Processing Algorithm for Extracting Clinical and Pathological Features of Breast Cancer From Pathology Reports 10
Totale 5.756
Categoria #
all - tutte 24.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.594


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020633 0 0 0 0 70 120 129 87 90 65 51 21
2020/20211.093 33 43 78 93 101 136 111 138 69 64 45 182
2021/2022742 81 52 63 33 24 72 33 45 46 79 70 144
2022/20231.251 149 352 172 105 102 185 29 34 24 34 32 33
2023/2024776 18 15 29 72 79 158 106 46 72 40 31 110
2024/2025855 129 306 135 132 153 0 0 0 0 0 0 0
Totale 5.756